APO Research
Talk to an analyst

APO RESEARCH · REPORT

PD-L1 and PIK3CA Testing Product

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global PD-L1 and PIK3CA Testing Product Market Outlook and Growth Opportunities 2026

31 December 2025198 pages

Choose your research edition.

Industry ResearchPD-L1 and PIK3CA Testing Product Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal PD-L1 and PIK3CA Testing Product Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal PD-L1 and PIK3CA Testing Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PD-L1 and PIK3CA Testing Product Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal PD-L1 and PIK3CA Testing Product Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global PD-L1 and PIK3CA Testing Product market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for PD-L1 and PIK3CA Testing Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for PD-L1 and PIK3CA Testing Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PD-L1 and PIK3CA Testing Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the PD-L1 and PIK3CA Testing Product market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the PD-L1 and PIK3CA Testing Product market include Roche, QIAGEN, Foundation Medicine, EntroGen, Amoy Diagnostics, Agilent Technologies and ACCB Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global PD-L1 and PIK3CA Testing Product market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of PD-L1 and PIK3CA Testing Product and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents PD-L1 and PIK3CA Testing Product sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the PD-L1 and PIK3CA Testing Product market size, projected growth trends, production technologies, key applications, and end-use industries.

PD-L1 and PIK3CA Testing Product Segment by Company

Roche

QIAGEN

Foundation Medicine

EntroGen

Amoy Diagnostics

Agilent Technologies

ACCB Biotech

PD-L1 and PIK3CA Testing Product Segment by Type

PD-L1

PIK3CA

PD-L1 and PIK3CA Testing Product Segment by Application

Hospital

Diagnostic Center

Others

PD-L1 and PIK3CA Testing Product Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global PD-L1 and PIK3CA Testing Product status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions PD-L1 and PIK3CA Testing Product market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify PD-L1 and PIK3CA Testing Product significant trends, drivers, influence factors in global and regions.

6. To analyze PD-L1 and PIK3CA Testing Product competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PD-L1 and PIK3CA Testing Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PD-L1 and PIK3CA Testing Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PD-L1 and PIK3CA Testing Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the PD-L1 and PIK3CA Testing Product market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global PD-L1 and PIK3CA Testing Product industry.

Chapter 3: Detailed analysis of PD-L1 and PIK3CA Testing Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of PD-L1 and PIK3CA Testing Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of PD-L1 and PIK3CA Testing Product in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. PD-L1 and PIK3CA Testing Product Industry Trends Table 2. PD-L1 and PIK3CA Testing Product Industry Drivers Table 3. PD-L1 and PIK3CA Testing Product Industry Opportunities and Challenges Table 4. PD-L1 and PIK3CA Testing Product Industry Restraints Table 5. Global PD-L1 and PIK3CA Testing Product Revenue by Company (US$ Million) & (2021-2026) Table 6. Global PD-L1 and PIK3CA Testing Product Revenue Share by Company (2021-2026) Table 7. Global PD-L1 and PIK3CA Testing Product Sales Volume by Company (K Units) & (2021-2026) Table 8. Global PD-L1 and PIK3CA Testing Product Sales Volume Share by Company (2021-2026) Table 9. Global PD-L1 and PIK3CA Testing Product Average Price (US$/Unit) of Company (2021-2026) Table 10. Global PD-L1 and PIK3CA Testing Product Company Ranking, (2024-2026) & (USD Million) Table 11. Global PD-L1 and PIK3CA Testing Product Key Company Manufacturing Base & Headquarters Table 12. Global PD-L1 and PIK3CA Testing Product Company, Product Type & Application Table 13. Global PD-L1 and PIK3CA Testing Product Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global PD-L1 and PIK3CA Testing Product by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of PD-L1 Table 18. Significant Companies of PIK3CA Table 19. Global PD-L1 and PIK3CA Testing Product Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global PD-L1 and PIK3CA Testing Product Sales Volume by Type (2021-2026) & (K Units) Table 21. Global PD-L1 and PIK3CA Testing Product Sales Volume by Type (2027-2032) & (K Units) Table 22. Global PD-L1 and PIK3CA Testing Product Sales Volume Share by Type (2021-2026) Table 23. Global PD-L1 and PIK3CA Testing Product Sales Volume Share by Type (2027-2032) Table 24. Global PD-L1 and PIK3CA Testing Product Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global PD-L1 and PIK3CA Testing Product Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global PD-L1 and PIK3CA Testing Product Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global PD-L1 and PIK3CA Testing Product Sales Value Share by Type (2021-2026) Table 28. Global PD-L1 and PIK3CA Testing Product Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Diagnostic Center Table 31. Significant Companies of Others Table 32. Global PD-L1 and PIK3CA Testing Product Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global PD-L1 and PIK3CA Testing Product Sales Volume by Application (2021-2026) & (K Units) Table 34. Global PD-L1 and PIK3CA Testing Product Sales Volume by Application (2027-2032) & (K Units) Table 35. Global PD-L1 and PIK3CA Testing Product Sales Volume Share by Application (2021-2026) Table 36. Global PD-L1 and PIK3CA Testing Product Sales Volume Share by Application (2027-2032) Table 37. Global PD-L1 and PIK3CA Testing Product Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global PD-L1 and PIK3CA Testing Product Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global PD-L1 and PIK3CA Testing Product Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global PD-L1 and PIK3CA Testing Product Sales Value Share by Application (2021-2026) Table 41. Global PD-L1 and PIK3CA Testing Product Sales Value Share by Application (2027-2032) Table 42. Global PD-L1 and PIK3CA Testing Product Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global PD-L1 and PIK3CA Testing Product Sales by Region (2021-2026) & (K Units) Table 44. Global PD-L1 and PIK3CA Testing Product Sales Market Share by Region (2021-2026) Table 45. Global PD-L1 and PIK3CA Testing Product Sales by Region (2027-2032) & (K Units) Table 46. Global PD-L1 and PIK3CA Testing Product Sales Market Share by Region (2027-2032) Table 47. Global PD-L1 and PIK3CA Testing Product Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global PD-L1 and PIK3CA Testing Product Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global PD-L1 and PIK3CA Testing Product Sales Value Share by Region (2021-2026) Table 50. Global PD-L1 and PIK3CA Testing Product Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global PD-L1 and PIK3CA Testing Product Sales Value Share by Region (2027-2032) Table 52. Global PD-L1 and PIK3CA Testing Product Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global PD-L1 and PIK3CA Testing Product Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global PD-L1 and PIK3CA Testing Product Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global PD-L1 and PIK3CA Testing Product Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global PD-L1 and PIK3CA Testing Product Sales by Country (2021-2026) & (K Units) Table 57. Global PD-L1 and PIK3CA Testing Product Sales Market Share by Country (2021-2026) Table 58. Global PD-L1 and PIK3CA Testing Product Sales by Country (2027-2032) & (K Units) Table 59. Global PD-L1 and PIK3CA Testing Product Sales Market Share by Country (2027-2032) Table 60. Global PD-L1 and PIK3CA Testing Product Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global PD-L1 and PIK3CA Testing Product Sales Value Market Share by Country (2021-2026) Table 62. Global PD-L1 and PIK3CA Testing Product Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global PD-L1 and PIK3CA Testing Product Sales Value Market Share by Country (2027-2032) Table 64. Roche Company Information Table 65. Roche Business Overview Table 66. Roche PD-L1 and PIK3CA Testing Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Roche PD-L1 and PIK3CA Testing Product Product Portfolio Table 68. Roche Recent Development Table 69. QIAGEN Company Information Table 70. QIAGEN Business Overview Table 71. QIAGEN PD-L1 and PIK3CA Testing Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. QIAGEN PD-L1 and PIK3CA Testing Product Product Portfolio Table 73. QIAGEN Recent Development Table 74. Foundation Medicine Company Information Table 75. Foundation Medicine Business Overview Table 76. Foundation Medicine PD-L1 and PIK3CA Testing Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Foundation Medicine PD-L1 and PIK3CA Testing Product Product Portfolio Table 78. Foundation Medicine Recent Development Table 79. EntroGen Company Information Table 80. EntroGen Business Overview Table 81. EntroGen PD-L1 and PIK3CA Testing Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. EntroGen PD-L1 and PIK3CA Testing Product Product Portfolio Table 83. EntroGen Recent Development Table 84. Amoy Diagnostics Company Information Table 85. Amoy Diagnostics Business Overview Table 86. Amoy Diagnostics PD-L1 and PIK3CA Testing Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Amoy Diagnostics PD-L1 and PIK3CA Testing Product Product Portfolio Table 88. Amoy Diagnostics Recent Development Table 89. Agilent Technologies Company Information Table 90. Agilent Technologies Business Overview Table 91. Agilent Technologies PD-L1 and PIK3CA Testing Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Agilent Technologies PD-L1 and PIK3CA Testing Product Product Portfolio Table 93. Agilent Technologies Recent Development Table 94. ACCB Biotech Company Information Table 95. ACCB Biotech Business Overview Table 96. ACCB Biotech PD-L1 and PIK3CA Testing Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. ACCB Biotech PD-L1 and PIK3CA Testing Product Product Portfolio Table 98. ACCB Biotech Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. PD-L1 and PIK3CA Testing Product Distributors List Table 102. PD-L1 and PIK3CA Testing Product Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. PD-L1 and PIK3CA Testing Product Product Image Figure 2. Global PD-L1 and PIK3CA Testing Product Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PD-L1 and PIK3CA Testing Product Sales Value (2021-2032) & (US$ Million) Figure 4. Global PD-L1 and PIK3CA Testing Product Sales (2021-2032) & (K Units) Figure 5. Global PD-L1 and PIK3CA Testing Product Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global PD-L1 and PIK3CA Testing Product Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. PD-L1 Image Figure 10. PIK3CA Image Figure 11. Global PD-L1 and PIK3CA Testing Product Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global PD-L1 and PIK3CA Testing Product Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global PD-L1 and PIK3CA Testing Product Sales Volume Share by Type (2021-2032) Figure 14. Global PD-L1 and PIK3CA Testing Product Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global PD-L1 and PIK3CA Testing Product Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global PD-L1 and PIK3CA Testing Product Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Diagnostic Center Image Figure 19. Others Image Figure 20. Global PD-L1 and PIK3CA Testing Product Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global PD-L1 and PIK3CA Testing Product Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global PD-L1 and PIK3CA Testing Product Sales Volume Share by Application (2021-2032) Figure 23. Global PD-L1 and PIK3CA Testing Product Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global PD-L1 and PIK3CA Testing Product Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global PD-L1 and PIK3CA Testing Product Sales Value Share by Application (2021-2032) Figure 26. Global PD-L1 and PIK3CA Testing Product Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global PD-L1 and PIK3CA Testing Product Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global PD-L1 and PIK3CA Testing Product Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global PD-L1 and PIK3CA Testing Product Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America PD-L1 and PIK3CA Testing Product Sales Value (2021-2032) & (US$ Million) Figure 31. North America PD-L1 and PIK3CA Testing Product Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe PD-L1 and PIK3CA Testing Product Sales Value (2021-2032) & (US$ Million) Figure 33. Europe PD-L1 and PIK3CA Testing Product Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific PD-L1 and PIK3CA Testing Product Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific PD-L1 and PIK3CA Testing Product Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America PD-L1 and PIK3CA Testing Product Sales Value (2021-2032) & (US$ Million) Figure 37. South America PD-L1 and PIK3CA Testing Product Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa PD-L1 and PIK3CA Testing Product Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa PD-L1 and PIK3CA Testing Product Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. PD-L1 and PIK3CA Testing Product Value Chain Figure 125. Manufacturing Cost Structure Figure 126. PD-L1 and PIK3CA Testing Product Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • PD-L1
  • PIK3CA
Applications
  • Hospital
  • Diagnostic Center
  • Others
Companies covered
  • Roche
  • QIAGEN
  • Foundation Medicine
  • EntroGen
  • Amoy Diagnostics
  • Agilent Technologies
  • ACCB Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global PD-L1 and PIK3CA Testing Product Sales Value (2021-2032)
  4. 1.2.2 Global PD-L1 and PIK3CA Testing Product Sales Volume (2021-2032)
  5. 1.2.3 Global PD-L1 and PIK3CA Testing Product Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 PD-L1 and PIK3CA Testing Product Market Dynamics
  1. 2.1 PD-L1 and PIK3CA Testing Product Industry Trends
  2. 2.2 PD-L1 and PIK3CA Testing Product Industry Drivers
  3. 2.3 PD-L1 and PIK3CA Testing Product Industry Opportunities and Challenges
  4. 2.4 PD-L1 and PIK3CA Testing Product Industry Restraints
3 PD-L1 and PIK3CA Testing Product Market by Company
  1. 3.1 Global PD-L1 and PIK3CA Testing Product Company Revenue Ranking in 2025
  2. 3.2 Global PD-L1 and PIK3CA Testing Product Revenue by Company (2021-2026)
  3. 3.3 Global PD-L1 and PIK3CA Testing Product Sales Volume by Company (2021-2026)
  4. 3.4 Global PD-L1 and PIK3CA Testing Product Average Price by Company (2021-2026)
  5. 3.5 Global PD-L1 and PIK3CA Testing Product Company Ranking (2024-2026)
  6. 3.6 Global PD-L1 and PIK3CA Testing Product Company Manufacturing Base and Headquarters
  7. 3.7 Global PD-L1 and PIK3CA Testing Product Company Product Type and Application
  8. 3.8 Global PD-L1 and PIK3CA Testing Product Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global PD-L1 and PIK3CA Testing Product Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 PD-L1 and PIK3CA Testing Product Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 PD-L1 and PIK3CA Testing Product Market by Type
  1. 4.1 PD-L1 and PIK3CA Testing Product Type Introduction
  2. 4.1.1 PD-L1
  3. 4.1.2 PIK3CA
  4. 4.2 Global PD-L1 and PIK3CA Testing Product Sales Volume by Type
  5. 4.2.1 Global PD-L1 and PIK3CA Testing Product Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global PD-L1 and PIK3CA Testing Product Sales Volume by Type (2021-2032)
  7. 4.2.3 Global PD-L1 and PIK3CA Testing Product Sales Volume Share by Type (2021-2032)
  8. 4.3 Global PD-L1 and PIK3CA Testing Product Sales Value by Type
  9. 4.3.1 Global PD-L1 and PIK3CA Testing Product Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global PD-L1 and PIK3CA Testing Product Sales Value by Type (2021-2032)
  11. 4.3.3 Global PD-L1 and PIK3CA Testing Product Sales Value Share by Type (2021-2032)
5 PD-L1 and PIK3CA Testing Product Market by Application
  1. 5.1 PD-L1 and PIK3CA Testing Product Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Diagnostic Center
  4. 5.1.3 Others
  5. 5.2 Global PD-L1 and PIK3CA Testing Product Sales Volume by Application
  6. 5.2.1 Global PD-L1 and PIK3CA Testing Product Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global PD-L1 and PIK3CA Testing Product Sales Volume by Application (2021-2032)
  8. 5.2.3 Global PD-L1 and PIK3CA Testing Product Sales Volume Share by Application (2021-2032)
  9. 5.3 Global PD-L1 and PIK3CA Testing Product Sales Value by Application
  10. 5.3.1 Global PD-L1 and PIK3CA Testing Product Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global PD-L1 and PIK3CA Testing Product Sales Value by Application (2021-2032)
  12. 5.3.3 Global PD-L1 and PIK3CA Testing Product Sales Value Share by Application (2021-2032)
6 PD-L1 and PIK3CA Testing Product Regional Sales and Value Analysis
  1. 6.1 Global PD-L1 and PIK3CA Testing Product Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global PD-L1 and PIK3CA Testing Product Sales by Region (2021-2032)
  3. 6.2.1 Global PD-L1 and PIK3CA Testing Product Sales by Region: 2021-2026
  4. 6.2.2 Global PD-L1 and PIK3CA Testing Product Sales by Region (2027-2032)
  5. 6.3 Global PD-L1 and PIK3CA Testing Product Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global PD-L1 and PIK3CA Testing Product Sales Value by Region (2021-2032)
  7. 6.4.1 Global PD-L1 and PIK3CA Testing Product Sales Value by Region: 2021-2026
  8. 6.4.2 Global PD-L1 and PIK3CA Testing Product Sales Value by Region (2027-2032)
  9. 6.5 Global PD-L1 and PIK3CA Testing Product Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America PD-L1 and PIK3CA Testing Product Sales Value (2021-2032)
  12. 6.6.2 North America PD-L1 and PIK3CA Testing Product Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe PD-L1 and PIK3CA Testing Product Sales Value (2021-2032)
  15. 6.7.2 Europe PD-L1 and PIK3CA Testing Product Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific PD-L1 and PIK3CA Testing Product Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific PD-L1 and PIK3CA Testing Product Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America PD-L1 and PIK3CA Testing Product Sales Value (2021-2032)
  21. 6.9.2 South America PD-L1 and PIK3CA Testing Product Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa PD-L1 and PIK3CA Testing Product Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa PD-L1 and PIK3CA Testing Product Sales Value Share by Country, 2025 VS 2032
7 PD-L1 and PIK3CA Testing Product Country-level Sales and Value Analysis
  1. 7.1 Global PD-L1 and PIK3CA Testing Product Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global PD-L1 and PIK3CA Testing Product Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global PD-L1 and PIK3CA Testing Product Sales by Country (2021-2032)
  4. 7.3.1 Global PD-L1 and PIK3CA Testing Product Sales by Country (2021-2026)
  5. 7.3.2 Global PD-L1 and PIK3CA Testing Product Sales by Country (2027-2032)
  6. 7.4 Global PD-L1 and PIK3CA Testing Product Sales Value by Country (2021-2032)
  7. 7.4.1 Global PD-L1 and PIK3CA Testing Product Sales Value by Country (2021-2026)
  8. 7.4.2 Global PD-L1 and PIK3CA Testing Product Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt PD-L1 and PIK3CA Testing Product Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt PD-L1 and PIK3CA Testing Product Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt PD-L1 and PIK3CA Testing Product Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche PD-L1 and PIK3CA Testing Product Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Roche PD-L1 and PIK3CA Testing Product Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 QIAGEN
  8. 8.2.1 QIAGEN Company Information
  9. 8.2.2 QIAGEN Business Overview
  10. 8.2.3 QIAGEN PD-L1 and PIK3CA Testing Product Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 QIAGEN PD-L1 and PIK3CA Testing Product Product Portfolio
  12. 8.2.5 QIAGEN Recent Developments
  13. 8.3 Foundation Medicine
  14. 8.3.1 Foundation Medicine Company Information
  15. 8.3.2 Foundation Medicine Business Overview
  16. 8.3.3 Foundation Medicine PD-L1 and PIK3CA Testing Product Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Foundation Medicine PD-L1 and PIK3CA Testing Product Product Portfolio
  18. 8.3.5 Foundation Medicine Recent Developments
  19. 8.4 EntroGen
  20. 8.4.1 EntroGen Company Information
  21. 8.4.2 EntroGen Business Overview
  22. 8.4.3 EntroGen PD-L1 and PIK3CA Testing Product Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 EntroGen PD-L1 and PIK3CA Testing Product Product Portfolio
  24. 8.4.5 EntroGen Recent Developments
  25. 8.5 Amoy Diagnostics
  26. 8.5.1 Amoy Diagnostics Company Information
  27. 8.5.2 Amoy Diagnostics Business Overview
  28. 8.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Product Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Amoy Diagnostics PD-L1 and PIK3CA Testing Product Product Portfolio
  30. 8.5.5 Amoy Diagnostics Recent Developments
  31. 8.6 Agilent Technologies
  32. 8.6.1 Agilent Technologies Company Information
  33. 8.6.2 Agilent Technologies Business Overview
  34. 8.6.3 Agilent Technologies PD-L1 and PIK3CA Testing Product Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Agilent Technologies PD-L1 and PIK3CA Testing Product Product Portfolio
  36. 8.6.5 Agilent Technologies Recent Developments
  37. 8.7 ACCB Biotech
  38. 8.7.1 ACCB Biotech Company Information
  39. 8.7.2 ACCB Biotech Business Overview
  40. 8.7.3 ACCB Biotech PD-L1 and PIK3CA Testing Product Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 ACCB Biotech PD-L1 and PIK3CA Testing Product Product Portfolio
  42. 8.7.5 ACCB Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 PD-L1 and PIK3CA Testing Product Value Chain Analysis
  2. 9.1.1 PD-L1 and PIK3CA Testing Product Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 PD-L1 and PIK3CA Testing Product Sales Mode & Process
  6. 9.2 PD-L1 and PIK3CA Testing Product Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 PD-L1 and PIK3CA Testing Product Distributors
  9. 9.2.3 PD-L1 and PIK3CA Testing Product Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst